Video – How the LRC-TriCEPS Service works
Watch the video to see how the LRC-TriCEPS™ technology works
LRC-TriCEPS™ is a novel approach which enables the identification of cell surface receptors and off-targets on the living cells for a wide range of orphan ligands, such as:
- Peptides
- Protein
- Antibodies
- Engineered affinity binders
- Viruses
Contact form
Please fill out all mandatory (*) fields.
LRC-TriCEPS Service – Customers Testimonials
- BioMed
- Follicum
- Igenica Biotherapeutics
- QIMR Berghofer
- University of Miami
- Münster University Hospital
- University of Manitoba
- The Rockefeller University
- Medizinische Hochschule Hannover
- Igenica Biotherapeutics (USA)
- University of California San Francisco (UCSF)
- CEDOC – Centro de Estudos de Doenças Crónicas
- Washington University School of Medicine
Customers Testimonials – LRC-TriCEPS Service
Testimonials from our customers who have used the LRC-TriCEPS technology – in collaboration with Dualsystems Biotech AG.
LRC-TriCEPS customers worldwide
Over 200 satisfied customers from 28 countries.
Years working with LRC-TriCEPS
LRC-TriCEPS clients served
Cell types used for LRC-TriCEPS
Years of experience
LRC-TriCEPS publications worldwide
LRC-TriCEPS / HATRIC-LRC Publications
Concerning the LRC-TriCEPS or HATRIC-LRC platforms.
Validation of extracellular ligand–receptor interactions by Flow‑TriCEPS
Cardiac Targeting Peptide, a Novel Cardiac Vector: Studies in Bio-Distribution, Imaging Application, and Mechanism of Transduction
Leukocyte differentiation by histidine-rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation of anti-tumor immunity
Glycomics and Proteomics Approaches to Investigate Early Adenovirus–Host Cell Interactions
HATRIC-based identification of receptors for orphan ligands
Staphylococcal Superantigens Use LAMA2 as a Coreceptor GPCT signaling To Activate T Cells
Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma
Phenotypic screening—the fast track to novel antibody discovery
Identification of Putative Receptors for the Novel Adipokine CTRP3 Using Ligand-Receptor Capture Technology
Serum stimulation of CCR7 chemotaxis due to coagulation factor XIIa-dependent production of high-molecular-weight kininogen domain 5
Laminin targeting of a peripheral nerve-highlighting peptide enables degenerated nerve visualization
Identification of cell surface receptors for the novel adipokine CTRP3
Dilp8 requires the neuronal relaxin receptor Lgr3 to couple growth to developmental timing
- Received:
- Accepted:
- Published online:
A Mass Spectrometric-Derived Cell Surface Protein Atlas
Protter